PT Sarana Meditama Metropolitan Tbk (IDX: SAME) Stock Analysis
Worldreview1989 - Financial Analysis, Healthcare Business Outlook, and Investment Risks for American Readers PT Sarana Meditama Metropolitan Tbk (IDX: SAME) operates in Indonesia's private healthcare industry. For investors researching international healthcare stocks, SAME offers exposure to hospital services, medical demand, and Indonesia's healthcare market.
This article examines the company's business model, financial performance, valuation considerations, and investment risks through an analytical framework designed for U.S. readers.
1. Company Overview
PT Sarana Meditama Metropolitan Tbk
Ticker: IDX: SAME
Industry: Healthcare and hospital services
Country: Indonesia
Official investor information should be checked through the company's disclosures and the Indonesia Stock Exchange.
PT Sarana Meditama Metropolitan Tbk is a publicly listed Indonesian healthcare company. The investment case is connected to the demand for medical services, hospital operations, and the capital required to maintain and expand healthcare facilities.
For American investors, the stock belongs in the broader category of emerging-market healthcare equities. However, SAME is an Indonesian rupiah-denominated stock, not a U.S.-listed healthcare stock such as HCA Healthcare or Tenet Healthcare.
Official research sources
Indonesia Stock Exchange — IDX official website . Use the listed-company and financial-report sections to verify SAME's filings.
Company website — Company information and investor disclosures, subject to availability.
Otoritas Jasa Keuangan — OJK official website . Indonesian capital-market regulatory information.
Data note: The available search results did not provide a verified current SAME financial statement or share price. Therefore, this article does not invent revenue, net income, EPS, debt, or valuation figures. Those figures should be taken from the latest official filing before publication.
2. The Healthcare Investment Thesis
A hospital operator can generate revenue from several sources:
Hospital admissions
Inpatient care, room charges, medical treatment, and procedures.
Outpatient and specialist care
Consultations, diagnostic services, and recurring medical visits.
Healthcare infrastructure
Hospital capacity, medical equipment, and facility expansion.
What could drive future revenue?
More patients and higher hospital utilization.
Growth in specialist services and higher-value procedures.
Expansion of hospital capacity.
Changes in medical tariffs and payer reimbursement.
Greater healthcare spending in Indonesia.
These are business drivers to investigate, not forecasts of SAME's actual future growth.
3. Financial Analysis Framework
The following framework is designed for an American reader reviewing an Indonesian hospital stock. It identifies the numbers that matter and how to interpret them.
Revenue and earnings
Metric
Why it matters
Revenue growth
Shows whether the hospital business is expanding.
EBITDA margin
Indicates operating profitability before interest, taxes, depreciation, and amortization.
Net profit margin
Shows how much revenue remains as net income.
EPS
Measures earnings attributable to each share.
Operating cash flow
Tests whether reported earnings translate into cash.
Metric | Why it matters |
|---|---|
Revenue growth | Shows whether the hospital business is expanding. |
EBITDA margin | Indicates operating profitability before interest, taxes, depreciation, and amortization. |
Net profit margin | Shows how much revenue remains as net income. |
EPS | Measures earnings attributable to each share. |
Operating cash flow | Tests whether reported earnings translate into cash. |
The Indonesia Stock Exchange defines key stock-screening ratios such as P/E, PBV, ROE, ROA, DER, and NPM using financial information submitted by listed companies.
Balance sheet and capital intensity
Hospitals require buildings, medical equipment, maintenance, and qualified staff. A profitable hospital company can still face financial pressure if it spends heavily on expansion or carries substantial debt.
The most important balance-sheet questions are:
Is total debt rising faster than operating earnings?
Does operating cash flow cover capital expenditure?
Is interest expense reducing net income?
Are new hospitals generating adequate returns on invested capital?
Is equity growing through retained earnings or new share issuance?
Valuation
Three ratios are especially useful:
Ratio | Formula | Interpretation |
|---|---|---|
P/E | Share price ÷ EPS | How much investors pay for earnings. |
PBV | Share price ÷ book value per share | Market value relative to accounting equity. |
EV/EBITDA | Enterprise value ÷ EBITDA | Useful for comparing businesses with different debt levels. |
These ratios should be calculated using the same reporting period and a verified market price. A low P/E or PBV does not, by itself, establish that a stock is undervalued.
4. Financial Numbers to Verify Before Publishing
For a stock article intended for U.S. readers, the financial section should use the latest available audited annual report and interim financial statements.
How to complete the financial table
Use the company's latest financial statements to fill in the following template:
Financial metric | Latest year | Previous year |
|---|---|---|
Revenue (IDR) | — | — |
Net income (IDR) | — | — |
Net profit margin | — | — |
Total assets (IDR) | — | — |
Total liabilities (IDR) | — | — |
Total equity (IDR) | — | — |
Operating cash flow (IDR) | — | — |
Capital expenditure (IDR) | — | — |
Financial calculations
Revenue growth
Net profit margin
Return on equity
Free cash flow
These calculations can be used to assess whether revenue growth is accompanied by improving profitability and cash generation.
5. What American Readers Should Know About Indonesian Healthcare Stocks
A U.S. investor comparing SAME with American hospital stocks should consider several structural differences.
Currency exposure
SAME trades in Indonesian rupiah. An American investor's dollar return depends on both the stock price and the IDR/USD exchange rate.
For example, if the stock rises 10% in rupiah terms but the rupiah depreciates 10% against the dollar, the dollar return is approximately:
This is an illustrative currency calculation, not a prediction of SAME's return.
Healthcare payment systems
Indonesian healthcare revenue may be affected by:
National Health Insurance (JKN/BPJS Kesehatan).
Private insurance.
Corporate healthcare arrangements.
Direct patient payments.
The relevant question for investors is how much of SAME's revenue comes from each payer category and whether reimbursement rates support sustainable hospital margins.
Liquidity and market access
SAME is listed on the Indonesia Stock Exchange rather than a major U.S. exchange. American investors should check:
Broker access to IDX.
Trading liquidity.
Bid-ask spreads.
Foreign investor rules.
Currency conversion costs.
Tax treatment and custody arrangements.
The IDX publishes sector-level trading statistics and financial-ratio information for listed companies.
6. Unique Analytical Component: Hospital Revenue Quality
One useful way to analyze a hospital stock is to separate revenue growth from revenue quality.
A company can report higher revenue for different reasons:
Revenue growth quality framework
1. Patient volume
Demand
More patients and higher occupancy may indicate stronger underlying demand.
2. Revenue per patient
Mix
Higher-value procedures and specialist services can increase revenue per patient.
3. Operating margin
Efficiency
Revenue growth is more meaningful when it translates into sustainable operating profit.
4. Cash conversion
Financial quality
Operating cash flow helps determine whether earnings are being converted into cash.
Analytical equation
A simplified hospital revenue model is:
Revenue≈Patient Volume×Average Revenue per Patient\text{Revenue} \approx \text{Patient Volume} \times \text{Average Revenue per Patient}Revenue≈Patient Volume×Average Revenue per Patient
For inpatient services, a more detailed model could use:
Inpatient Revenue≈Available Beds×Occupancy Rate×Revenue per Occupied Bed Day\text{Inpatient Revenue} \approx \text{Available Beds} \times \text{Occupancy Rate} \times \text{Revenue per Occupied Bed Day}Inpatient Revenue≈Available Beds×Occupancy Rate×Revenue per Occupied Bed Day
This is a conceptual model. Actual hospital revenue includes outpatient services, diagnostics, pharmacy, procedures, and other revenue streams.
What to look for in SAME's disclosures: Revenue growth accompanied by higher utilization, improving margins, and healthy operating cash flow would provide a more complete picture than revenue growth alone.
7. Risks of Investing in SAME Stock
1. Reimbursement risk
Changes in government healthcare reimbursement or insurance payment arrangements can affect hospital revenue and profitability.
2. Operating cost risk
Medical supplies, medicines, salaries, utilities, and equipment maintenance can pressure margins.
3. Expansion risk
New hospitals and medical equipment require substantial investment. Returns may take time to materialize.
4. Debt and interest-rate risk
Borrowing can support expansion but increases interest expenses and financial obligations.
5. Currency risk
A U.S.-based investor is exposed to movements in the Indonesian rupiah.
6. Stock liquidity risk
Trading volume and bid-ask spreads can affect the ability to buy or sell shares at the desired price.
7. Regulatory risk
Healthcare businesses are affected by licensing, hospital regulations, medical standards, and government policy.
8. Valuation risk
Even a growing healthcare business can produce poor investment returns if purchased at an excessive valuation.
8. SAME vs. U.S. Healthcare Stocks
The following is a business-model comparison, not a ranking of investment attractiveness.
Factor | SAME | U.S. hospital stocks |
|---|---|---|
Primary market | Indonesia | United States |
Trading currency | Indonesian rupiah | U.S. dollar |
Healthcare system | Indonesian healthcare system | U.S. healthcare system |
Investor exposure | Indonesian hospital industry | U.S. hospital industry |
Currency risk for U.S. investors | IDR/USD exposure | Generally lower direct FX exposure |
Financial reporting | Indonesian listed-company disclosures | U.S. SEC filings for U.S.-listed companies |
Main operating drivers | Patient demand, reimbursement, utilization, costs | Patient demand, reimbursement, utilization, costs |
Possible U.S. comparison companies include HCA Healthcare and Tenet Healthcare. Their business operations and financial results should be analyzed separately from SAME.
Official U.S. filings can be accessed through the U.S. Securities and Exchange Commission EDGAR database .
9. Which Is Right for You?
This section is a framework for deciding what information to investigate, rather than an investment recommendation.
If you are researching Indonesian healthcare
Focus on SAME's official financial statements, hospital operations, and healthcare market exposure.
If you are a U.S. investor
Check broker access, currency exposure, trading costs, and the latest verified valuation.
If you are comparing hospital companies
Compare revenue growth, margins, cash flow, debt, and valuation using the same reporting periods.
10. Investment Checklist
Before using this article as a basis for an investment decision, review:
Latest audited annual report.
Latest quarterly or interim financial statements.
Current IDX share price.
Revenue and net profit trends.
EPS and valuation ratios.
Debt, interest expense, and operating cash flow.
Hospital occupancy and capacity disclosures.
BPJS/private payer exposure.
Currency and trading liquidity risks.
Company announcements and material events.
Conclusion
PT Sarana Meditama Metropolitan Tbk (IDX: SAME) represents an opportunity to research Indonesia's publicly listed hospital industry. The company's investment case should be evaluated through hospital revenue growth, operating margins, cash flow, balance-sheet strength, reimbursement exposure, and valuation.
For American readers, the additional considerations are Indonesian rupiah exposure, access to the IDX market, and differences between Indonesian and U.S. healthcare systems.
The key analytical takeaway: Hospital revenue growth should be examined together with utilization, profitability, and cash conversion. Without verified current financial statements and share-price data, a reliable numerical valuation or investment conclusion cannot be established.
Primary Sources & References
Indonesia Stock Exchange — Official IDX website . Listed-company information, financial reports, and market data.
PT Sarana Meditama Metropolitan Tbk official website — Company information and investor disclosures.
Otoritas Jasa Keuangan — OJK official website . Capital-market regulations and investor information.
U.S. Securities and Exchange Commission — EDGAR company filings . U.S. company filings for comparative research.
About the Author
David Mulyana is the founder and editor of WorldReview1989, an independent publication dedicated to finance, investing, insurance, business, technology, and digital marketing.
He researches and writes in-depth articles that help readers understand complex financial topics through clear explanations, practical insights, and data-driven analysis. His editorial focus includes stock market investing, cryptocurrencies, banking, personal finance, business insurance, real estate, startup strategies, and emerging technology trends.
Every article published on WorldReview1989 is created with a commitment to accuracy, transparency, and reader value. Content is reviewed regularly to reflect the latest market developments, industry updates, and publicly available information from trusted sources.
Editorial Principles
- Accuracy before speed
- Independent and unbiased analysis
- Clear, easy-to-understand explanations
- Information supported by reputable public sources
- Regular updates to maintain content relevance
Areas of Expertise
- Personal Finance
- Investing & Stock Market
- Cryptocurrency & Blockchain
- Insurance
- Banking
- Real Estate
- Business & Entrepreneurship
- Digital Marketing
- Financial Technology (FinTech)
About WorldReview1989
WorldReview1989 provides educational content for readers seeking reliable information about finance, investment opportunities, insurance, business strategies, and technology. The website aims to simplify complex financial concepts and empower readers to make informed decisions.
Disclaimer: The information published on WorldReview1989 is for educational and informational purposes only. It should not be considered financial, legal, tax, or investment advice. Readers should consult qualified professionals before making financial decisions.
David Mulyana writes about stocks, financial markets, investment strategies, insurance and emerging-market opportunities, with a focus on helping readers understand financial data and investment risks.